- Home
- VAC vs MLTX Comparison
VAC vs MLTX Comparison
Compare VAC & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VAC
- MLTX
- Stock Information
- Founded
- VAC 1984
- MLTX 2021
- Country
- VAC United States
- MLTX Switzerland
- Employees
- VAC N/A
- MLTX N/A
- Industry
- VAC Real Estate
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- VAC Finance
- MLTX Health Care
- Exchange
- VAC Nasdaq
- MLTX Nasdaq
- Market Cap
- VAC 2.1B
- MLTX 2.4B
- IPO Year
- VAC N/A
- MLTX N/A
- Fundamental
- Price
- VAC $65.80
- MLTX $39.01
- Analyst Decision
- VAC Buy
- MLTX Strong Buy
- Analyst Count
- VAC 8
- MLTX 8
- Target Price
- VAC $92.25
- MLTX $77.71
- AVG Volume (30 Days)
- VAC 580.1K
- MLTX 301.3K
- Earning Date
- VAC 05-07-2025
- MLTX 05-12-2025
- Dividend Yield
- VAC 4.80%
- MLTX N/A
- EPS Growth
- VAC 7.38
- MLTX N/A
- EPS
- VAC 5.85
- MLTX N/A
- Revenue
- VAC $3,301,000,000.00
- MLTX N/A
- Revenue This Year
- VAC $58.21
- MLTX $103.42
- Revenue Next Year
- VAC $3.22
- MLTX N/A
- P/E Ratio
- VAC $11.26
- MLTX N/A
- Revenue Growth
- VAC 4.26
- MLTX N/A
- 52 Week Low
- VAC $49.22
- MLTX $31.42
- 52 Week High
- VAC $100.32
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- VAC 51.55
- MLTX 50.57
- Support Level
- VAC $64.21
- MLTX $37.79
- Resistance Level
- VAC $73.16
- MLTX $40.71
- Average True Range (ATR)
- VAC 1.72
- MLTX 1.78
- MACD
- VAC -0.36
- MLTX -0.02
- Stochastic Oscillator
- VAC 17.78
- MLTX 58.61
About VAC Marriott Vacations Worldwide Corporation
Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.